Richard W. Paul & Associates’s CRISPR Therapeutics CRSP Stock Holding History

Richard W. Paul & Associates’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$1.65K	Hold
2024 Q3	$1.97K	Hold
2024 Q2	$2.27K	Hold
2024 Q1	$2.86K	Hold
2023 Q4	$2.63K	Hold
2023 Q3	$1.91K	Hold
2023 Q2	$2.36K	Hold
2023 Q1	$1.9K	Hold
2022 Q4	$1.71K	Buy